Clinical Cardiology Alert – March 1, 2012
March 1, 2012
View Issues
-
Rivaroxaban after Acute Coronary Syndrome
After acute coronary syndromes (ACS), patients remain at risk for recurrent cardiovascular events. Antiplatelet agents are the mainstay of secondary preventive strategies aimed at reducing the rate of recurrent events. -
Asymptomatic Severe Aortic Stenosis
The management of asymptomatic patients with severe aortic stenosis (AS) is controversial. Patients meeting standard echocardiographic criteria for severe stenosis have a variety of pressure gradients and flow rates that can be divided into four categories based on normal flow vs low flow (NF vs LF) and low gradient vs high gradient (LG vs HG), where LF is defined as a stroke volume index (SVI) of < 35 mL/m2 and LG is a mean gradient < 40 mmHg. -
Value of the ECG in Asymptomatic AS
Although electrocardiogram (ECG) left ventricular hypertrophy (LVH), especially with ST-T changes (strain pattern), is known to be of prognostic value in patients with aortic stenosis, its valve in patients who are being followed is unclear. -
Stroke Risk in Atrial Fibrillation
The Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT) tested two hypotheses. -
Medical Therapy or Stenting for Aortoiliac PAD?
Peripheral arterial disease (PAD) can cause symptomatic claudication and it can reduce quality of life. -
Physician Experience and the Risk of Procedural Complications
In this study, Freeman and colleagues analyzed data from the National Cardiovascular Data Registry-ICD Registry (NCDR-ICD Registry) to examine the effects of physician procedure volume on in-hospital complications and death. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
New treatment for prostate cancer; avastin and breast cancer; new CMS disclosure rule; and FDA actions.